US Patent Issued to MetiMedi Pharmaceuticals on March 17 for "Methods of treating chronic inflammatory diseases" (South Korean Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,576,107, issued on March 17, was assigned to MetiMedi Pharmaceuticals Co. Ltd. (Uiwang-si, South Korea).

"Methods of treating chronic inflammatory diseases" was invented by Chong-Hwan Chang (Incheon, South Korea) and Keun-Yeong Jeong (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to method of treating chronic inflammatory diseases in subjects in need thereof by administering calcium lactate as an active agent. The calcium lactate can be provided in a pharmaceutical, food, or nutrient composition."

The patent was filed on Sept. 11, 2023, under Application No. 18/464,965.

*For further information, including ima...